SMS Pharmaceuticals P/E Ratio
SMS Pharmaceuticals (SMSPHARMA) P/E ratio is 35.0 (High), EPS (TTM) ₹11.15, current price ₹377.35 on NSE vs historical average P/E of 15.74 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Analyse SMS Pharmaceuticals ownership pattern to track promoter, FII and institutional holdings.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SMSPHARMA P/E Ratio — Valuation Signal & Historical Context
SMS Pharmaceuticals P/E 35.0 vs historical average 15.74, range 7.68–25.31 — signal: Overvalued. Browse SMSPHARMA cash flow statement for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PE of 35.0, suggesting caution for new investments
- Current PE is 122.3% above historical average
- Trading at discount to sector average PE of 49.12
SMS Pharmaceuticals P/E Ratio Historical Trend
SMSPHARMA annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 35.0 vs historical average 15.74. For live price, revenue and the complete fundamental profile, see SMS Pharmaceuticals share price chart.
SMSPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation
SMS Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 25.31 | 10.14 | ₹256.68 | NSE | High |
| 2024 | 15.35 | 7.81 | ₹119.85 | NSE | Moderate |
| 2023 | 18.24 | 4.58 | ₹83.55 | NSE | Moderate |
| 2021 | 12.77 | 9.3 | ₹118.75 | NSE | Low |
| 2020 | 7.68 | 5.42 | ₹41.65 | NSE | Low |
| 2019 | 15.11 | 4.56 | ₹68.90 | NSE | Moderate |
SMSPHARMA vs Healthcare Peers — P/E Ratio Comparison
SMS Pharmaceuticals P/E 35.0 vs Healthcare average 49.12, median 28.77 — range 0.97–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |